Pediatrix Medical Group, Inc. Stock Price, News & Analysis

Mednax, Inc. (NYSE: MD) will hold an investor conference call on August 6, 2021, at 9:00 a.m. ET to discuss its operational results for the quarter and six months ending June 30, 2021. A detailed press release will be provided that morning. The call will be accessible via Mednax's website. Established in 1979, Mednax comprises over 2,300 physicians across 39 states and Puerto Rico, focusing on enhancing patient care through evidence-based methods and telehealth. Forward-looking statements in the PR highlight potential risks and uncertainties affecting future performance.

Mednax, Inc. (NYSE: MD) announced that CVS Aetna has voluntarily dismissed its litigation against the company, concluding a case initiated in 2018. This dismissal was officially filed in court on July 14. CEO Mark S. Ordan expressed relief over the resolution, emphasizing Mednax's commitment to patient care and hope for a positive relationship with CVS Aetna moving forward. Mednax is a national medical group focused on providing high-quality, cost-effective physician services across specialties.

Mednax, Inc. (NYSE: MD) reported Q1 2021 earnings of $0.06 per share, with an adjusted EPS of $0.24. Net revenue rose to $447 million, a 1.4% increase year-over-year. Patient volumes were affected by COVID-19, but a 3.6% increase in same-unit revenue was noted. Adjusted EBITDA improved to $45.5 million, aided by provider relief funds. Cash reserves fell to $270 million after redeeming $750 million in senior notes. Despite challenges, Mednax remains focused on operational efficiency and support for clinicians.

Mednax, Inc. (NYSE: MD) will host an investor conference call on May 7, 2021, at 9:00 a.m. ET to discuss its operational results for Q1 2021. An accompanying press release will be issued that morning before market opening. Mednax is a national medical group with over 2,300 physicians across 39 states and Puerto Rico, focused on enhancing patient care through evidence-based practices.

Oteemo, Inc. has successfully assisted Mednax, Inc. (NYSE: MD) in significantly reducing its application deployment time from months to minutes by implementing a DevSecOps practice. This initiative aims to enhance Mednax's IT capabilities, which support high-quality patient care. The collaboration fosters a culture shift at Mednax, focusing on a product-oriented mindset and measurable engineering practices. Senior Director Adam Martin emphasized the partnership's role in integrating innovation to better serve patients.

Mednax, Inc. (NYSE: MD) has announced its affiliation with NightLight Pediatric Urgent Care, based in Houston. This partnership marks the start of a new strategy aimed at enhancing pediatric care, incorporating urgent, primary, and telehealth services. Mednax plans to expand NightLight's existing services, offering a comprehensive pediatric continuum, including subspecialties and wellness programs. The cash transaction is expected to be immediately accretive to earnings. NightLight, operational since 2007, serves over 90,000 patients annually across eight locations in Houston.

Mednax, Inc. (NYSE: MD) announced two investor presentations scheduled for February 25 and March 1, 2021. The company will present at Citi’s 2021 Healthcare Services Conference at 2:25 p.m. ET and at the J.P. Morgan Global High Yield & Leveraged Finance Conference at 10:00 a.m. ET. Both presentations will be available via live audio webcasts. Established in 1979, Mednax is a national medical group with over 2,300 physicians operating in 39 states and Puerto Rico, focusing on enhancing patient care and outcomes through innovative practices.

Mednax, Inc. (NYSE: MD) reported earnings of $0.05 per share for Q4 2020, with adjusted EPS of $0.25. The company's net revenue for the quarter was $417 million, down from $458.6 million in Q4 2019. Mednax's overall same-unit revenue declined by 9.5%, impacted by the COVID-19 pandemic. For the full year, revenue from continuing operations was $1.73 billion, a decrease from $1.78 billion in 2019. Mednax ended the year with $1.12 billion in cash. CEO Mark S. Ordan expressed confidence in the company's future post-COVID, focusing on efficiency and financial strength.

Mednax, Inc. (NYSE: MD) will hold an investor conference call on February 18, 2021, at 9:00 a.m. ET to discuss operational results for the year ended December 31, 2020. A detailed press release will be issued before the conference. Mednax is a national health solutions partner, providing services through over 2,300 physicians in 39 states and Puerto Rico, focusing on enhancing patient outcomes with evidence-based tools and telehealth programs.